UnitedHealth Group Set for Further Acquisitions

Despite intensifying regulatory scrutiny on its deals, UnitedHealth Group (NYSE: UNH) remains poised for further acquisitions. During the past two years, the insurance giant has completed a slew of acquisitions spanning much of the health care continuum — including hospice, palliative care and home health — as well as health care technology, largely through its […]

Executive Moves at UnitedHealth Group, Treasure Coast Hospice

UnitedHealth Group’s President, COO Change UnitedHealth Group (NYSE: UNH) has announced the retirement of President and COO Dirk McMahon. The company has not yet named his predecessor. McMahon will step down on April 1 after more than two decades with the insurance giant reported in a recent Securities and Exchange Commission (SEC) filing. He most […]

DOJ Considers Lawsuit to Block Amedisys-Optum Transaction

The U.S. Department of Justice (DOJ) is reportedly mulling a possible lawsuit to block the acquisition of Amedisys (NASDAQ: AMED) by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. Amedisys stock dipped 0.6% following reports of a lawsuit under consideration, SeekingAlpha reported. Optum, a subsidiary of UnitedHealth Group (NYSE: UHN), in June 2023 penned its agreement […]

Justice Department Launches UnitedHealth Group Antitrust Investigation

In case you missed it, Hospice News has launched a new specialty publication for palliative care professionals. You can subscribe to Palliative Care News here: Subscribe today! The U.S. Justice Department is investigating UnitedHealth Group (NYSE: UNH) due to antitrust concerns. During the past two years, the insurance giant has completed a slew of acquisitions […]

Growing Palliative Care a Key Priority for Amedisys in 2024

Want to read more palliative care-focused content like this? Subscribe to Palliative Care News today! Amedisys (NASDAQ: AMED) is pushing forward on palliative care growth in 2024 through its innovation arm, Contessa. The company acquired Contessa in 2021 for $250 million. Contessa’s specialties are high-acuity care in the home, including hospital-at-home and skilled nursing facility-at-home programs. […]

Hospice Investors to Watch in 2024

Though the number of hospice M&A deals plummeted in 2023 compared to prior years, deals are still being made, and the industry may see a rebound in 2024. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Only three hospice deals took place in the third […]

JVs a Major Growth Engine for Hospices in 2024

Moving into 2024, more hospices see joint ventures or similar partnerships to be a major growth engine. Nearly half of 143 respondents to Hospice News’ 2024 Outlook Survey, conducted with Homecare Homebase, said that joint ventures and partnerships were the growth tactics they planned to pursue the most this year. More than 62% of the […]

Contessa’s Lessons Learned on Risk-Based Palliative Care

As Contessa Health pioneers a growing value-based palliative care-at-home program, they’ve encountered some learning curves when it comes to operating within a new payment system. Contessa is a subsidiary of Amedisys (NASDAQ: AMED), which the home health and hospice provider acquired in 2021 for $250 million. Contessa’s specialty is high-acuity care in the home, including […]

How PE Firms Are Adjusting Hospice Exit Strategies in a Shifting Market

Private equity firms typically turn around and sell an asset within three to five years post-acquisition. However, some may slow that cycle down in today’s economic environment. The presence of private equity firms in the hospice arena has expanded exponentially during the past several years. But this year, deal volume slowed across the board. While […]